搜索临床试验以:CDX-011
总计1174个结果
-
National Cancer Institute (NCI)完全的
-
NantCell, Inc.完全的乳腺癌 | 胰腺癌 | 卵巢癌 | 肺癌 | 结肠癌 | 甲状腺癌美国
-
Paul Graham FisherNational Cancer Institute (NCI); National Institutes of Health (NIH)终止
-
CureTech LtdTeva Branded Pharmaceutical Products R&D, Inc.终止
-
Merck Sharp & Dohme LLC完全的
-
Ariad Pharmaceuticals完全的
-
VA Office of Research and DevelopmentThe Clowes Fund, Inc.完全的
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex Therapeutics招聘中
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)主动,不招人
-
Northwestern UniversityNational Cancer Institute (NCI); Gateway for Cancer Research终止
-
James Larner, MDCelldex Therapeutics终止
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans Affairs完全的
-
Acrotech Biopharma Inc.Clinipace Worldwide; Beckloff Associates, Inc.; Kansas City Bioanalytical Laboratories完全的
-
Medivation, Inc.完全的
-
Aura Biosciences招聘中眼黑色素瘤 | 葡萄膜黑色素瘤 | 脉络膜黑色素瘤 | 不确定的病变美国, 澳大利亚, 英国
-
Forest Laboratories完全的
-
VA Office of Research and Development招聘中
-
Assistance Publique - Hôpitaux de ParisBristol-Myers Squibb终止
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)完全的肉瘤 | 胶质母细胞瘤 | 复发性卵巢癌 | 复发性子宫体癌 | 间变性少突星形细胞瘤 | 间变性星形细胞瘤 | 转移性肾细胞癌 | 复发性肺癌 | 复发性肾细胞癌 | IV 期皮肤黑色素瘤 | 复发性黑色素瘤 | IIIB 期皮肤黑色素瘤 | IIIC 期皮肤黑色素瘤 | 转移性前列腺癌 | II期子宫体癌 | 间变性少突胶质细胞瘤 | 复发性膀胱癌 | 复发性乳腺癌 | 复发性结直肠癌 | 复发性食管癌 | 复发性胃癌 | 复发性前列腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | IV 期前列腺癌 | 雌激素受体阴性 | 雌激素受体阳性 | 复发性肝细胞癌 | 激素抵抗性前列腺癌 | IIA期卵巢癌 | IIB期卵巢癌 | IIC 期卵巢癌 | IIIA期卵巢癌 | IIIB期卵巢癌 | IIIC... 及其他条件美国